With a future vaccine against Covid-19 in high demand, the executive director of the European Medicines Agency (EMA) has recommended that modelling be used to identify the population that will need it most.
“When we grant a marketing authorisation in Europe for a vaccine, it will be impossible for us to guarantee at the same time the availability of this substance everywhere”, he said in an exchange with MEPs on the European Parliament Committee on Public Health on Monday 18 May.